Skip to main content
. 2014 Oct 28;64(4):1193–1201. doi: 10.2337/db14-0667

Figure 1.

Figure 1

Study design flowchart. After screening and subject characterization, patients were randomly assigned to either 2 weeks of acipimox treatment or 2 weeks of placebo treatment. At the end of both treatments, mitochondrial function, ectopic lipid accumulation, and insulin sensitivity were assessed. After a washout period of 4 weeks, patients entered in the other intervention arm such that all patients served as their own control.